Pantoprazole is a first-generation proton pump inhibitor (PPI) used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It is grouped under the following drug class(es): Proton Pump Inhibitors. Its therapeutic use is listed as gastrointestinal agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Altopan and Zovanta. Its PubChem CID is 4679.
Pantoprazole
| CAS No | 102625-70-7 |
|---|---|
| Molecular Formula | C16H15F2N3O4S |
| Molecular Weight | 383.4 g/mol |
| Synonyms | 6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pantoprazole is a first-generation proton pump inhibitor (PPI) used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome.
The listed CAS number is 102625-70-7.
The listed molecular formula is C16H15F2N3O4S.
The listed molecular weight is 383.4 g/mol.
6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole.
The source lists Altopan and Zovanta.